Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Advanced Drug Delivery Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Advanced Drug Delivery Industry
  • 1.7 COVID-19 Impact: Advanced Drug Delivery Market Trends

    • 2 Global Advanced Drug Delivery Quarterly Market Size Analysis

    • 2.1 Advanced Drug Delivery Business Impact Assessment - COVID-19
      • 2.1.1 Global Advanced Drug Delivery Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Advanced Drug Delivery Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Advanced Drug Delivery Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Advanced Drug Delivery Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Advanced Drug Delivery Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Advanced Drug Delivery Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Advanced Drug Delivery Market
    • 3.5 Key Manufacturers Advanced Drug Delivery Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Advanced Drug Delivery Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Polymeric Drug Delivery
      • 1.4.2 Implants & IUD's
      • 1.4.3 Sustained Release
      • 1.4.4 Targeted Drug Delivery
      • 1.4.5 Prodrugs
    • 4.2 By Type, Global Advanced Drug Delivery Market Size, 2019-2021
      • 4.2.1 By Type, Global Advanced Drug Delivery Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Advanced Drug Delivery Price, 2020-2021

    5 Impact of Covid-19 on Advanced Drug Delivery Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Diagnostic Centers
      • 5.5.3 Ambulatory Surgical Centers/Clinics
      • 5.5.4 Home Care Settings
      • 5.5.5 Other End Users
    • 5.2 By Application, Global Advanced Drug Delivery Market Size, 2019-2021
      • 5.2.1 By Application, Global Advanced Drug Delivery Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Advanced Drug Delivery Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Merck & Co
      • 7.1.1 Merck & Co Business Overview
      • 7.1.2 Merck & Co Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.1.3 Merck & Co Advanced Drug Delivery Product Introduction
      • 7.1.4 Merck & Co Response to COVID-19 and Related Developments
    • 7.2 Antares Pharma
      • 7.2.1 Antares Pharma Business Overview
      • 7.2.2 Antares Pharma Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.2.3 Antares Pharma Advanced Drug Delivery Product Introduction
      • 7.2.4 Antares Pharma Response to COVID-19 and Related Developments
    • 7.3 F. Hoffmann-La Roche
      • 7.3.1 F. Hoffmann-La Roche Business Overview
      • 7.3.2 F. Hoffmann-La Roche Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.3.3 F. Hoffmann-La Roche Advanced Drug Delivery Product Introduction
      • 7.3.4 F. Hoffmann-La Roche Response to COVID-19 and Related Developments
    • 7.4 Novartis
      • 7.4.1 Novartis Business Overview
      • 7.4.2 Novartis Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.4.3 Novartis Advanced Drug Delivery Product Introduction
      • 7.4.4 Novartis Response to COVID-19 and Related Developments
    • 7.5 Bayer
      • 7.5.1 Bayer Business Overview
      • 7.5.2 Bayer Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.5.3 Bayer Advanced Drug Delivery Product Introduction
      • 7.5.4 Bayer Response to COVID-19 and Related Developments
    • 7.6 Sanofi
      • 7.6.1 Sanofi Business Overview
      • 7.6.2 Sanofi Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.6.3 Sanofi Advanced Drug Delivery Product Introduction
      • 7.6.4 Sanofi Response to COVID-19 and Related Developments
    • 7.7 Glaxosmithkline
      • 7.7.1 Glaxosmithkline Business Overview
      • 7.7.2 Glaxosmithkline Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.7.3 Glaxosmithkline Advanced Drug Delivery Product Introduction
      • 7.7.4 Glaxosmithkline Response to COVID-19 and Related Developments
    • 7.8 3M
      • 7.8.1 3M Business Overview
      • 7.8.2 3M Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.8.3 3M Advanced Drug Delivery Product Introduction
      • 7.8.4 3M Response to COVID-19 and Related Developments
    • 7.9 Pfizer
      • 7.9.1 Pfizer Business Overview
      • 7.9.2 Pfizer Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.9.3 Pfizer Advanced Drug Delivery Product Introduction
      • 7.9.4 Pfizer Response to COVID-19 and Related Developments
    • 7.10 Johnson & Johnson
      • 7.10.1 Johnson & Johnson Business Overview
      • 7.10.2 Johnson & Johnson Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.10.3 Johnson & Johnson Advanced Drug Delivery Product Introduction
      • 7.10.4 Johnson & Johnson Response to COVID-19 and Related Developments
    • 7.11 Abbott Laboratories
      • 7.11.1 Abbott Laboratories Business Overview
      • 7.11.2 Abbott Laboratories Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.11.3 Abbott Laboratories Advanced Drug Delivery Product Introduction
      • 7.11.4 Abbott Laboratories Response to COVID-19 and Related Developments
    • 7.12 Allergan
      • 7.12.1 Allergan Business Overview
      • 7.12.2 Allergan Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.12.3 Allergan Advanced Drug Delivery Product Introduction
      • 7.12.4 Allergan Response to COVID-19 and Related Developments
    • 7.13 Baxter International
      • 7.13.1 Baxter International Business Overview
      • 7.13.2 Baxter International Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.13.3 Baxter International Advanced Drug Delivery Product Introduction
      • 7.13.4 Baxter International Response to COVID-19 and Related Developments
    • 7.14 Mylan Pharmaceutical
      • 7.14.1 Mylan Pharmaceutical Business Overview
      • 7.14.2 Mylan Pharmaceutical Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.14.3 Mylan Pharmaceutical Advanced Drug Delivery Product Introduction
      • 7.14.4 Mylan Pharmaceutical Response to COVID-19 and Related Developments
    • 7.15 Roche Holding
      • 7.15.1 Roche Holding Business Overview
      • 7.15.2 Roche Holding Advanced Drug Delivery Quarterly Production and Revenue, 2020
      • 7.15.3 Roche Holding Advanced Drug Delivery Product Introduction
      • 7.15.4 Roche Holding Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Advanced Drug Delivery Supply Chain Analysis
      • 8.1.1 Advanced Drug Delivery Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Advanced Drug Delivery Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Advanced Drug Delivery Distribution Channels
      • 8.2.2 Covid-19 Impact on Advanced Drug Delivery Distribution Channels
      • 8.2.3 Advanced Drug Delivery Distributors
    • 8.3 Advanced Drug Delivery Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Advanced Drug Delivery, including the following market information:
      Global Advanced Drug Delivery Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Advanced Drug Delivery Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Advanced Drug Delivery Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Advanced Drug Delivery Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Merck & Co, Antares Pharma, F. Hoffmann-La Roche, Novartis, Bayer, Sanofi, Glaxosmithkline, 3M, Pfizer, Johnson & Johnson, Abbott Laboratories, Allergan, Baxter International, Mylan Pharmaceutical, Roche Holding, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Polymeric Drug Delivery
      Implants & IUD's
      Sustained Release
      Targeted Drug Delivery
      Prodrugs

      Based on the Application:
      Hospitals
      Diagnostic Centers
      Ambulatory Surgical Centers/Clinics
      Home Care Settings
      Other End Users

      Buy now